Cellyan Biotechnology Ltd. (HKPD) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$1.89

From 52W high−92.64%

Volume11554.00

Market cap$4.46M

P/E (TTM)—

P/S (TTM)0.3x

Div yield—

Key dataNov 4, 2026

Open

$1.89

From 52W high

−92.64%

Volume

11554.00

Market cap

$4.46M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.5x

P/E (TTM)

—

RSI (14)

35.9

MomentumView details →

1D Return

−6.70%

YTD Return

−88.48%

SummaryUpdated Mar 1, 2026

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) is a recently public company that went public on January 15, 2025. Founded by Lap Sun Wong on August 17, 2023, and headquartered in Hong Kong, the company operates in the specialized niche of pharmaceutical cross-border e-commerce supply chain services. Despite being a relatively new entity, the company has established itself as a facilitator of international pharmaceutical trade, particularly focusing on over-the-counter (OTC) medications and cross-border logistics solutions.

Ask drillr about Cellyan Biotechnology Ltd. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−7.5x

EV/Sales

0.4x

P/S (TTM)

0.3x

P/B (TTM)

0.5x

ProfitabilityView details →

Gross Margin

10.32%

Net Margin

−8.46%

EBITDA Margin

−5.43%

ROE (TTM)

−11.85%

ROA (TTM)

−8.84%

Asset Turnover

1.20x

GrowthView details →

Revenue YoY

−33.87%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+2.28%

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

−6.70%

YTD Return

−88.48%

1Y Return

−92.21%

RSI (14)

35.9

vs 50D SMA

−29.32%

vs 200D SMA

−79.22%

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

3.86x

Quick Ratio

3.75x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

33.75M

Net Income (TTM)

−1.16M

Op. CF (TTM)

−182387.00

Latest newsMore news →

Cellyan Biotechnology announced a 1-for-20 reverse stock split of its Class A and Class B ordinary shares, effective at the market opening on October 26, 2026.14d ago

Similar companies

POMDOCTOR LtdPOM Bio Green Med Solution, Inc.BGMS Eocene Ltd.EOCN Plus Therapeutics, Inc.CNSY Bio Green Med Solution, Inc.BGMSP Hoth Therapeutics, Inc.RKTO Find similar companies →

Latest newsMore news →

Cellyan Biotechnology announced a 1-for-20 reverse stock split of its Class A and Class B ordinary shares, effective at the market opening on October 26, 2026.14d ago